The anti-ErbB2 antibody H2-18 and the pan-PI3K inhibitor GDC-0941 effectively inhibit trastuzumab-resistant ErbB2-overexpressing breast cancer | |
Wang, Lingfei; Yu, Xiaojie; Wang, Chao; Pan, Shujun; Liang, Beibei; Zhang, Yajun; Chong, Xiaodan; Meng, Yanchun; Dong, Jian; Zhao, Yirong | |
刊名 | ONCOTARGET |
2017 | |
卷号 | 8期号:32 |
关键词 | trastuzumab resistance GDC-0941 anti-ErbB2 antibody programmed cell death breast cancer |
ISSN号 | 1949-2553 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4268483 |
专题 | 上海健康医学院 |
推荐引用方式 GB/T 7714 | Wang, Lingfei,Yu, Xiaojie,Wang, Chao,et al. The anti-ErbB2 antibody H2-18 and the pan-PI3K inhibitor GDC-0941 effectively inhibit trastuzumab-resistant ErbB2-overexpressing breast cancer[J]. ONCOTARGET,2017,8(32). |
APA | Wang, Lingfei.,Yu, Xiaojie.,Wang, Chao.,Pan, Shujun.,Liang, Beibei.,...&Li, Bohua.(2017).The anti-ErbB2 antibody H2-18 and the pan-PI3K inhibitor GDC-0941 effectively inhibit trastuzumab-resistant ErbB2-overexpressing breast cancer.ONCOTARGET,8(32). |
MLA | Wang, Lingfei,et al."The anti-ErbB2 antibody H2-18 and the pan-PI3K inhibitor GDC-0941 effectively inhibit trastuzumab-resistant ErbB2-overexpressing breast cancer".ONCOTARGET 8.32(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论